|
|
||||||||
1 Department of Medicine, University of California, San Diego, California 92093; and 2 Department of Medicine, University of Vermont, Burlington, Vermont 05405
Sarcoplasmic
reticulum (SR)-mediated Ca2+ sequestration and release are
important determinants of cardiac contractility. In end-stage heart
failure SR dysfunction has been proposed to contribute to the impaired
cardiac performance. In this study we tested the hypothesis that a
targeted interference with SR function can be a primary cause of
contractile impairment that in turn might alter cardiac gene expression
and induce cardiac hypertrophy. To study this we developed a novel
animal model in which ryanodine, a substance that alters SR
Ca2+ release, was added to the drinking water of mice.
After 1 wk of treatment, in vivo hemodynamic measurements showed a 28%
reduction in the maximum speed of contraction
(+dP/dtmax) and a 24% reduction in the maximum
speed of relaxation (
dP/dtmax). The slowing of cardiac relaxation was confirmed in isolated papillary muscles. The
late phase of relaxation expressed as the time from 50% to 90%
relaxation was prolonged by 22%. After 4 wk of ryanodine
administration the animals had developed a significant cardiac
hypertrophy that was most prominent in both atria (right artrium
+115%, left atrium +100%, right ventricle +23%, and left ventricle
+13%). This was accompanied by molecular changes including a threefold
increase in atrial natriuretic factor mRNA and a sixfold increase in
-myosin heavy chain mRNA. Sarcoplasmic endoplasmic reticulum
Ca2+ mRNA was reduced by 18%. These data suggest that
selective impairment of SR function in vivo can induce changes in
cardiac gene expression and promote cardiac growth.
growth; inotropic agents; myocardial contraction; Ca2+ handling; endothelial cell coupling
This article has been cited by other articles:
![]() |
J. M. Goodman, G.-M. Busato, E. Frey, and Z. Sasson Left ventricular contractile function is preserved during prolonged exercise in middle-aged men J Appl Physiol, February 1, 2009; 106(2): 494 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. J. Schultz, B. J. Glascock, S. A. Witt, M. L. Nieman, K. J. Nattamai, L. H. Liu, J. N. Lorenz, G. E. Shull, T. R. Kimball, and M. Periasamy Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1146 - H1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Barry and E. M. Gilbert How Do {beta}-Blockers Improve Ventricular Function in Patients With Congestive Heart Failure? Circulation, May 20, 2003; 107(19): 2395 - 2397. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |